A supply of the Transdermal Autolytic Tuberculin, developed last year by Dr. H. J. Corper, director of the research department of the National Jewish Hospital at Denver, is on its way to the French Government, it was announced today at the hospital’s New York Office.
The request for this material, which makes possible speedier and simpler methods of detecting tuberculosis than those currently in general use, was made by the French Embassy in Washington on behalf of the Committee on Public Health and Social Assistance of the Republic of France.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
